Arima Genomics, Inc ., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...

A new study used 3M person-days of Apple Watch data to develop a foundation model that predicts medical conditions with ...

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...

The time of day that cancer drugs are administered could make a big difference to a patient's outcomes, and would be a ...

Researchers from the University of Oxford have benchmarked artificial intelligence (AI) tools capable of automatically ...

When cell division (mitosis) takes too long, it can be a sign that something is wrong with the cells, for example, DNA damage ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced that three abstracts will be presented at the San Antonio Breast Cancer ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena. The ALKOVE ...